Pharmatest (Finland)

Recent papers from Pharmatest (Finland)

1. Head-to-head comparison of 99mTc-MIP-1404 CZT SPECT/CT and 68Ga/PSMA-11 PET/CT for primary staging of high-risk prostate cancer: a phase II studyEJNMMI Research · 2026
2. Abstract 7542: In vitro and in vivo evaluation of bortezomib using the 5TGM1 cell line and a syngeneic mouse model of multiple myelomaCancer Research · 2026
3. Abstract 1598: Preclinical efficacy of a bispecific NK cell engager studied using a humanized multiple myeloma mouse modelCancer Research · 2026
4. Ex vivo expanded adaptive NK cells in combination with a bispecific NK cell engager targeting BCMA for synergistic control of multiple myelomaBlood · 2025
5. Burden of disease and treatment patterns for psoriatic arthritis in Finland: a nationwide real-world evidence studyScandinavian Journal of Rheumatology · 2025
6. Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer ModelsInternational Journal of Molecular Sciences · 2024
7. Three‐dimensional magnetic resonance cholangiography is superior to two‐dimensional single‐shot magnetic resonance cholangiography for visualization and image quality of the feline and canine biliary tract: A postmortem studyVeterinary Radiology & Ultrasound · 2024
8. Abstract 688: Radium-223 in combination with darolutamide exhibits synergistic antitumor efficacy in LNCaP prostate cancer modelsCancer Research · 2024
9. Abstract 2824: Establishing prostate cancer models for orthotopic and bone metastatic growth using the 22Rv1cell lineCancer Research · 2024
10. Abstract 2920: In vitro assays for investigating the effects of cancer therapeutics on boneCancer Research · 2024
11. Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse ModelCancers · 2023
12. Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis ModelCancers · 2023
13. Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer ModelInternational Journal of Molecular Sciences · 2023
14. Novel 2,7-Diazaspiro[4,4]nonane Derivatives to Inhibit Mouse and Human Osteoclast Activities and Prevent Bone Loss in Ovariectomized Mice without Affecting Bone FormationJournal of Medicinal Chemistry · 2020
15. Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung2020
16. The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone MetastasisInternational Journal of Molecular Sciences · 2019
17. Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal BoneJournal of Immunology Research · 2019
18. Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth modelJournal of bone oncology · 2019
19. Characterization a model of prostatic diseases and obstructive voiding induced by sex hormone imbalance in the Wistar and Noble ratsTranslational Andrology and Urology · 2019
20. Sequential treatment with doxorubicin and zoledronic acid has no additive effects in an aggressive model of established bone metastasesJournal of Cancer Metastasis and Treatment · 2019